Researchers find a considerable increase in HIV infection among injecting drug users.

A report that has been published in the British medical journal The Lancet shows that almost 3 million self-injecting drug users in the world are HIV-positive.

More than 40% drug users are infected in nine countries. The authors of the report showed concern about the lack of data from African countries and said the risk factors were greater in the continent. …Click here to read more

According to experts, men and women of certain age can prevent heart attack by taking aspirin daily.

Researchers from Nottingham and Sheffield universities analyzed data on more than 12,000 patients and they found aspirin proved beneficial for men aged 48 and above and women aged 57 and above.

Usually, blood vessel blockage because of some clot causes heart attacks and aspirin helps to avoid the formation of these blood clots. …Click here to read more

BUENOS AIRES, Argentina - Authorities are inquiring a possible association between the deaths of 14 kids and an experimental vaccine administered to them in a clinical trial, conducted by GlaxoSmithKline (GSK).

They are investigating whether the deaths are linked to the Synflorix vaccine, said an agency official. The drug, made to fight against pneumonia, ear infections and several other pneumococcal diseases by the London-based GSK, the world’s second-largest drug maker.

A U.S. spokeswoman for Glaxo, Sarah Alspach, said “the company is not attributing the deaths to the experimental vaccine, which is being tested in three Latin American countries and in other countries around the world.”
“We rely on their safety review,” Alspach said. “Safety is our primary concern, always, with the development of any new treatment.” …Click here to read more

The New York Times Sunday investigated how the Genentech cancer drug Avasting shows both the optimisms and predicaments of modern medication because it offers incremental paybacks for cancer patients, the drug is expensive and concerns have been greater than before about its security and efficacy.

The drug which is observed as a wonder-drug for its knack to stop blood supply to cancers costs as much as $100,000 per annum and had deals of $3.5 billion last year. Research expresses that drug prolongs the lives of victims with colon, lung and breath malignancy. Some patients and physicians say Avastin perks up the quality of life allowing patients to do daily functions devoid of tiredness, but such benefits are not easy to substantiate, reported by Times.
…Click here to read more